NCT04221152 A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 ) Status UNKNOWN Phase PHASE3
NCT04206787 The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer Status COMPLETED Phase N/A
NCT04194645 A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink. Status COMPLETED Phase PHASE1
NCT04184297 Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy Status COMPLETED Phase N/A
NCT04180813 Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose Status TERMINATED Phase N/A
NCT04179890 The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib Status COMPLETED Phase N/A
NCT04176536 A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body Status COMPLETED Phase PHASE1
NCT04172701 A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD) Status COMPLETED Phase N/A
NCT04161014 The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial Status UNKNOWN Phase PHASE2
NCT04157751 A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure Status COMPLETED Phase PHASE3
NCT04156035 Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine Status COMPLETED Phase NA
NCT04153929 A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. Status COMPLETED Phase PHASE2
NCT04147260 Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin Status COMPLETED Phase PHASE1
NCT04147247 A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread Status COMPLETED Phase PHASE1
NCT04147234 A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors) Status COMPLETED Phase PHASE1
NCT04138823 A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) Status COMPLETED Phase PHASE1
NCT04138758 Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS Status COMPLETED Phase N/A
NCT04137289 A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1